LA
₹2,323.00
-25.00(-1.06%)
LAURUSLABS₹2,323.00-1.06%
Group Companies
Foreign Flows
sector level — not this stockHealthcare sector+₹3 Crnet foreign buying
2026-09-16 to 2026-09-endThis is the flow into the whole Healthcare sector, not into LAURUSLABS. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.
Supply Chain
suppliers and customers in the graphMacro Sensitivity
rates, currency, commoditiesRevenue by Segment
Business Group
Geographic Exposure
revenue, imports, currencyScenario analysis
stated assumptions, shown workingsLAURUSLABS exposure summary
Laurus Labs Limited reports a single business segment, Manufacturer of Generics API, Generics FDF, Synthesis and Bio Technology. Laurus Labs Limited is a constituent of 10 indices, with its largest weights in NIFTY Pharma (7.82%), NIFTY Healthcare Index (7.30%), NIFTY Midcap 50 (3.75%). 26 exchange-traded funds hold the stock.
| Index memberships | 10 |
|---|---|
| ETFs holding | 26 |